Stay updated on Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows a new revision tag for v3.6.6, replacing the previous v3.6.5. This indicates a software or UI update rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T18:29:00.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows a new revision identifier (v3.6.5), replacing the previous v3.6.4, indicating a deployment of a newer site version and no evident changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-10T12:59:23.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added and Revision: v3.6.3 was removed. This reflects a site-wide update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-07-27T05:56:46.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added the revision indicator 'Revision: v3.6.3' in the footer and removed 'Revision: v3.6.2'. This reflects a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-07-05T13:43:20.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page's software revision has been updated from v3.6.0 to v3.6.2, indicating a backend/frontend update. The study content and available information remain the same.
    Difference
    0.1%
    Check dated 2026-06-28T08:26:46.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    Recruitment status 'No longer looking for participants' is displayed on the study details page, and new help/navigation sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added. The Intervention/Treatment header is updated, and the revision tag now shows v3.6.0, replacing the previous v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-14T06:21:41.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.